Skip header and navigation

11 records – page 1 of 1.

Atrial fibrillation and catheter ablation

https://libcat.nshealth.ca/en/permalink/chpams35948
Nova Scotia Health Authority. QEII. Division of Cardiology, Halifax Infirmary. Halifax, NS: Nova Scotia Health Authority , 2018.
Pamphlet Number
1230
Available Online
View Pamphlet
Atrial fibrillation is when the chambers of the heart (the atria) fibrillate (quiver). This can cause a rapid, irregular heart rhythm. This pamphlet reviews the causes and treatment of this heart problem. Catheter ablation is a non-surgical procedure that may be used when medication is not controlling your heart rhythm or symptoms. This pamphlet reviews how catheter ablation is done, risks, what to expect after your procedure, activities to avoid, and signs and symptoms to watch for.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Division of Cardiology, Halifax Infirmary
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document (11 p.) : digital, PDF file
Subjects (MeSH)
Atrial Fibrillation
Heart
Arrhythmias, Cardiac
Subjects (LCSH)
Atrial fibrillation
Arrhythmia
Heart beat
Abstract
Atrial fibrillation is when the chambers of the heart (the atria) fibrillate (quiver). This can cause a rapid, irregular heart rhythm. This pamphlet reviews the causes and treatment of this heart problem. Catheter ablation is a non-surgical procedure that may be used when medication is not controlling your heart rhythm or symptoms. This pamphlet reviews how catheter ablation is done, risks, what to expect after your procedure, activities to avoid, and signs and symptoms to watch for.
Responsibility
Prepared by: Division of Cardiology, Halifax Infirmary
Pamphlet Number
1230
Less detail

Atrial Fibrillation and Percutaneous Coronary Intervention : A Case-based Guide to Oral Anticoagulation, Antiplatelet Therapy and Stenting

https://libcat.nshealth.ca/en/permalink/provcat41420
Andrea Rubboli, Gregory Y. H. Lip, editors. --Cham: Springer , 2017.
Available Online
View e-Book
Location
Online
This book considers paradigmatic clinical cases in order to cast light on key issues relating to elective or emergency stent implantation and the use of oral anticoagulation (OAC) in patients with atrial fibrillation. The topics addressed include the optimal periprocedural antithrombotic treatment (uninterrupted vs interrupted OAC, intraprocedural use of heparin and glycoprotein IIb/IIIa inhibitors, etc.), the most appropriate type of stent (bare metal vs drug eluting vs "bioactive"), the optim…
Available Online
View e-Book
Other Authors
Rubboli, Andrea
Lip, Gregory Y. H.
Responsibility
Andrea Rubboli, Gregory Y. H. Lip, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
2017
Physical Description
1 online resource (viii, 212 pages) : 52 illus., 30 illus. in color
ISBN
9783319424002
9783319423982 (print ed.)
Subjects (MeSH)
Anticoagulants - therapeutic use
Atrial Fibrillation - drug therapy
Atrial Fibrillation - surgery
Percutaneous Coronary Intervention - methods
Vitamin K - therapeutic use
Abstract
This book considers paradigmatic clinical cases in order to cast light on key issues relating to elective or emergency stent implantation and the use of oral anticoagulation (OAC) in patients with atrial fibrillation. The topics addressed include the optimal periprocedural antithrombotic treatment (uninterrupted vs interrupted OAC, intraprocedural use of heparin and glycoprotein IIb/IIIa inhibitors, etc.), the most appropriate type of stent (bare metal vs drug eluting vs "bioactive"), the optimal regimen (e.g., triple therapy of OAC, aspirin, and clopidogrel vs the combination of OAC and a single antiplatelet agent), and the most suitable duration of the antithrombotic treatment prescribed at discharge (1 vs 6-12 months). The case-based management recommendations will be of wide practical value in the current health care context, where percutaneous coronary intervention is available even to patients with relevant co-morbidities, such as those warranting long-term OAC, and the indications for OAC are much broader than in the past. The book will appeal especially to clinical and interventional cardiologists, internal medicine specialists, hematologists, and family physicians and will also be of interest to cardiology and internal medicine residents and fellows.
Contents
Atrial fibrillation on vitamin K-antagonists undergoing elective coronary artery stenting for stable effort angina -- Atrial fibrillation on NOAC (dabigatran) undergoing elective coronary artery stenting for stable effort angina -- Atrial fibrillation on vitamin K-antagonist undergoing urgent coronary stenting for non ST-elevation acute coronary syndrome -- Atrial fibrillation on NOAC (rivaroxaban) undergoing urgent coronary stenting for non ST-elevation acute coronary syndrome -- Atrial fibrillation on vitamin K-antagonist undergoing emergency primary coronary stenting for ST-elevation acute myocardial infarction -- Atrial fibrillation on NOAC (apixaban) undergoing emergency primary coronary stenting for ST-elevation acute myocardial infarction -- Atrial fibrillation early complicating acute coronary syndrome treated with coronary artery stenting -- New-onset atrial fibrillation in a stable patient with remote coronary artery stenting -- Urgent surgery early after coronary stenting in a patient with atrial fibrillation on triple therapy of warfarin, aspirin and clopidogrel -- Urgent surgery early after coronary stenting in a patjent with atrial fibrillation on triple therapy of NOAC (a factor Xa-inhibitor), aspirin and clopidogrel -- Major bleeding early after coronary stenting in a patient with atrial fibrillation on triple therapy of warfarin, aspirin and clopidogrel -- Major bleeding early after coronary stenting in a patient with atrial fibrillation on triple therapy of NOAC (dabigatran), aspirin and clopidogrel.
Format
e-Book
Location
Online
Less detail

Atrial Fibrillation : From Bench to Bedside

https://libcat.nshealth.ca/en/permalink/provcat30398
edited by Andrea Natale, José Jalife. --Totowa, NJ: Humana Press , c2008.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Natale, Andrea
Other Authors
Jalife, José
Responsibility
edited by Andrea Natale, José Jalife
Place of Publication
Totowa, NJ
Publisher
Humana Press
Date of Publication
c2008
Series Title
Contemporary cardiology (Totowa, N.J. : Unnumbered)
ISBN
9781597451635
Subjects (MeSH)
Atrial Fibrillation - diagnosis
Atrial Fibrillation - physiopathology
Atrial Fibrillation - therapy
Catheter Ablation - methods
Subjects (LCSH)
Cardiology
Heart - Surgery
Format
e-Book
Location
Online
Less detail

Atrial fibrillation therapy

https://libcat.nshealth.ca/en/permalink/provcat33699
Gheorghe-Andrei Dan, Antoni Bayés de Luna, John Camm, editors. --London: Springer , c2014.
Available Online
View e-Book
Location
Online
The paradigm for atrial fibrillation (AF) management has changed significantly in recent years. A new era has begun for the prevention of one of the most tremendous complication of AF, stroke. Prevention of ischemic stroke in AF patients with oral anticoagulants represents a huge challenge because of the narrow therapeutic change of these drugs, interindividual and intraindividual variability, and the unsatisfactory time in therapeutically range (TTR) with this type of medication.
Available Online
View e-Book
Corporate Author
International Society of Cardiovascular Pharmacotherapy
Other Authors
Dan, G. Andrei
Bayés de Luna, Antoni
Camm, A. John
Responsibility
Gheorghe-Andrei Dan, Antoni Bayés de Luna, John Camm, editors
Place of Publication
London
Publisher
Springer
Date of Publication
c2014
Physical Description
1 online resource (xiv, 188 pages)
Series Title
Current cardiovascular therapy
ISBN
9781447154754 (electronic bk.)
9781447154747
Subjects (MeSH)
Atrial Fibrillation - drug therapy
Subjects (LCSH)
Atrial fibrillation
Cardiology
Abstract
The paradigm for atrial fibrillation (AF) management has changed significantly in recent years. A new era has begun for the prevention of one of the most tremendous complication of AF, stroke. Prevention of ischemic stroke in AF patients with oral anticoagulants represents a huge challenge because of the narrow therapeutic change of these drugs, interindividual and intraindividual variability, and the unsatisfactory time in therapeutically range (TTR) with this type of medication.
Contents
Epidemiology, burden and unmet needs in atrial fibrillation -- Inside molecular mechanisms and pharmacological targets of atrial fibrillation -- Novel oral anticoagulants for stroke prevention in patients with non-valvular atrial fibrillation -- Upstream therapy in the treatment of atrial fibrillation -- Drug therapy for rhythm and rate control in atrial fibrillation -- Changing the paradigm to understand and manage atrial fibrillation -- Guidelines and current recommendations in atrial fibrillation.
Format
e-Book
Location
Online
Less detail

Catheter ablation of atrial fibrillation

https://libcat.nshealth.ca/en/permalink/provcat38352
editors, Catherine M. Otto, J. Ward Kennedy-Hamilton. --[Philadelphia, PA]: Elsevier , c2014.
Available Online
View Video
Access
Registration required for PDF access.
Location
Online
Available Online
View Video
Other Authors
Otto, Catherine M.
Kennedy-Hamilton, J. Ward
Responsibility
editors, Catherine M. Otto, J. Ward Kennedy-Hamilton
Place of Publication
[Philadelphia, PA]
Publisher
Elsevier
Date of Publication
c2014
Physical Description
1 online resource : col. ill., video
Series
Procedures consult
Series Title
Procedures consult (ClinicalKey)
Subjects (MeSH)
Atrial Fibrillation - surgery
Catheter Ablation
Access
Registration required for PDF access.
Format
Video
Location
Online
Less detail
Nova Scotia Health Authority. QEII. Pharmacy Department. Halifax, NS: Nova Scotia Health Authority , 2018.
Pamphlet Number
0252
Available Online
View Pamphlet
Digoxin is a medication used to treat heart failure and certain types of irregular heartbeats (arrhythmias). Toloxin® is the brand name of digoxin. This pamphlet explains how to take digoxin, drugs and foods to avoid, warnings, possible side effects, and symptoms that you should mention to your doctor, nurse practitioner, or pharmacist.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Pharmacy Department
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2018
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Digoxin
Atrial Fibrillation
Heart Failure
Subjects (LCSH)
Digoxin
Atrial fibrillation
Heart failure
Abstract
Digoxin is a medication used to treat heart failure and certain types of irregular heartbeats (arrhythmias). Toloxin® is the brand name of digoxin. This pamphlet explains how to take digoxin, drugs and foods to avoid, warnings, possible side effects, and symptoms that you should mention to your doctor, nurse practitioner, or pharmacist.
Responsibility
Prepared by: Pharmacy Department
Pamphlet Number
0252
Less detail

Elective cardioversion for atrial fibrillation

https://libcat.nshealth.ca/en/permalink/provcat38355
editors, Catherine M. Otto, J. Ward Kennedy-Hamilton. --[Philadelphia, PA]: Elsevier , c2014.
Available Online
View Video
Access
Registration required for PDF access.
Location
Online
Available Online
View Video
Other Authors
Otto, Catherine M.
Kennedy-Hamilton, J. Ward
Responsibility
editors, Catherine M. Otto, J. Ward Kennedy-Hamilton
Place of Publication
[Philadelphia, PA]
Publisher
Elsevier
Date of Publication
c2014
Physical Description
1 online resource : col. ill., video
Series
Procedures consult
Series Title
Procedures consult (ClinicalKey)
Subjects (MeSH)
Atrial Fibrillation - therapy
Access
Registration required for PDF access.
Format
Video
Location
Online
Less detail

Essentials of atrial fibrillation

https://libcat.nshealth.ca/en/permalink/provcat33365
Yee Guan Yap, A John Camm. ([Revised edition]) --London: Springer Healthcare , c2014.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Yap, Yee Guan
Other Authors
Camm, A. John
Responsibility
Yee Guan Yap, A John Camm
Edition
[Revised edition]
Place of Publication
London
Publisher
Springer Healthcare
Date of Publication
c2014
Physical Description
1 online resource (viii, 47 pages)
ISBN
9781907673986 (electronic bk.)
9781858734385
Subjects (MeSH)
Atrial Fibrillation
Subjects (LCSH)
Atrial fibrillation
Internal Medicine
Cardiology
Hematology
Contents
1. Epidemiology of atrial fibrillation -- 2. Pathogenesis of atrial fibrillation -- 3. Classification, diagnosis, and assessment of atrial fibrillation -- 4. Rate and rhythm control strategies for atrial fibrillation -- 5. Anticoagulant treatment strategies for atrial fibrillation.
Format
e-Book
Location
Online
Less detail

Innovative management of atrial fibrillation

https://libcat.nshealth.ca/en/permalink/provcat22364
Schwartzman, David. --Malden, MA: Blackwell Futura , 2005.
Call Number
WG 330 I58 2005
Location
Halifax Infirmary
Call Number
WG 330 I58 2005
Author
Schwartzman, David
Other Authors
Zenati, Marco A
Place of Publication
Malden, MA
Publisher
Blackwell Futura
Date of Publication
2005
Physical Description
195 p.
ISBN
1405122099
Subjects (MeSH)
Atrial Fibrillation - therapy
Format
Book
Location
Halifax Infirmary
Loan Period
3 weeks
Less detail

Left Atrial Appendage Closure : Mechanical Approaches to Stroke Prevention in Atrial Fibrillation

https://libcat.nshealth.ca/en/permalink/provcat39771
Jacqueline Saw, Saibal Kar, Matthew J. Price, editors. --Cham: Springer International Publishing : Imprint: Humana Press , c2016.
Available Online
View e-Book
Location
Online
This book provides a comprehensive overview of state-of-the-art left atrial appendage (LAA) closure, covering epidemiology of atrial fibrillation and stroke, LAA anatomy, surgical approaches, imaging for LAA closure, LAA closure procedure, and post-procedural management. LAA closure is a rapidly emerging field in stroke prevention for patients with atrial fibrillation. Several percutaneous and surgical devices are now available in many countries, including WATCHMAN, Amplatzer Cardiac Plug and A…
Available Online
View e-Book
Other Authors
Saw, Jacqueline
Kar, Saibal
Price, Matthew J
Responsibility
Jacqueline Saw, Saibal Kar, Matthew J. Price, editors
Place of Publication
Cham
Publisher
Springer International Publishing : Imprint: Humana Press
Date of Publication
c2016
Physical Description
1 online resource (xi, 300 p. : 137 illus., 113 illus. in color)
Series Title
Contemporary cardiology
ISBN
9783319162805
9783319162799 (print ed.)
ISSN
2196-8969
Subjects (MeSH)
Atrial Appendage - diagnostic imaging
Atrial Appendage - surgery
Atrial Fibrillation - complications
Cardiac Surgical Procedures - methods
Stroke - prevention & control
Technology Assessment, Biomedical
Abstract
This book provides a comprehensive overview of state-of-the-art left atrial appendage (LAA) closure, covering epidemiology of atrial fibrillation and stroke, LAA anatomy, surgical approaches, imaging for LAA closure, LAA closure procedure, and post-procedural management. LAA closure is a rapidly emerging field in stroke prevention for patients with atrial fibrillation. Several percutaneous and surgical devices are now available in many countries, including WATCHMAN, Amplatzer Cardiac Plug and Amulet, and LARIAT devices, and many more are in clinical development and are being evaluated in research trials. As LAA closure is a technically challenging procedure, detailed knowledge of the rationale, anatomy, and technical approach of this modality guides clinicians in patient selection and facilitates procedural success. Left Atrial Appendage Closure is a valuable resource for interventional cardiologists, electrophysiologists, echocardiographers, radiographers, fellows, and residents in guiding the management of patients prior to, during, and following LAA closure.
Contents
Part I. Rationale for LAA Closure -- 1. Atrial Fibrillation and Stroke Epidemiology -- 2. Efficacy and Limitations of Warfarin and Novel Oral Anticoagulants with Atrial Fibrillation -- 3. Mechanistic Rationale for LAA Closure with AF and Stroke Prevention -- 4. LAA Anatomy -- Part II. Surgical Approaches for LAA Closure -- 5. Conventional Surgery for LAA Closure -- Part III. Imaging for LAA Closure -- 6. The Use of Transesophageal Echocardiography to Guide Percutaneous LAA Closure -- 7. The Use of Intracardiac Echocardiography (ICE) to Guide LAA Closure -- 8. CT Imaging for Percutaneous LAA Closure -- Part IV. Percutaneous LAA Closure Devices and Trial Results -- 9. PLAATO Device -- 10. WATCHMAN Device -- 11. WATCHMAN: Trials and Registries Results -- 12. Amplatzer Cardiac Plug and Amulet -- 13. ACP and Amulet: Trials and Registries Results -- 14. LARIAT: The Endo-Epicardial Technique for Left Atrial Appendage Exclusion -- 15. LARIAT: Trials and Registries Results -- 16. Novel Percutaneous LAA Closure Devices in Clinical or Preclinical Trials -- 17. Concomitant Left Atrial Appendage Closure and Catheter Ablation of Atrial Fibrillation -- Part V. Post-procedural Management and Issues -- 18. Procedural Complications and Management -- 19. Antiplatelet and Anticoagulant Strategies Following Left Atrial Appendage Closure -- 20. Device-Related Thrombi, Residual Leaks, and Consequences.
Format
e-Book
Location
Online
Less detail

Short Stay Management of Atrial Fibrillation

https://libcat.nshealth.ca/en/permalink/provcat40193
W. Frank Peacock, Carol L. Clark, editors. --Cham: Springer International Publishing : Imprint: Humana Press , c2016.
Available Online
View e-Book
Location
Online
This book provides a road map for the efficient and successful management of atrial fibrillation (AF) in the short stay unit. It describes the problem, defines the measures of successful treatment, elucidates interventions, and supplies the tools for achieving quality care. Organized in four parts, it covers the impact of AF on patient populations; the presentation and management of AF; the transition to the outpatient environment; and systems management. Topics include the economic consequence…
Available Online
View e-Book
Other Authors
Peacock, W. Frank
Clark, Carol L
Responsibility
W. Frank Peacock, Carol L. Clark, editors
Place of Publication
Cham
Publisher
Springer International Publishing : Imprint: Humana Press
Date of Publication
c2016
Physical Description
1 online resource (xiv, 289 p. : 40 illus., 24 illus. in color)
Series Title
Contemporary cardiology
ISBN
9783319313863
9783319313849 (print ed.)
ISSN
2196-8969
Subjects (MeSH)
Atrial Fibrillation - therapy
Disease Management
Hospitalization - trends
Abstract
This book provides a road map for the efficient and successful management of atrial fibrillation (AF) in the short stay unit. It describes the problem, defines the measures of successful treatment, elucidates interventions, and supplies the tools for achieving quality care. Organized in four parts, it covers the impact of AF on patient populations; the presentation and management of AF; the transition to the outpatient environment; and systems management. Topics include the economic consequences of AF; cardioversion and cardiac implantable electronic devices in AF management; education of the AF patient and discharge planning; and quality metrics in AF. The book also provides order sheets and process criteria with which institutions can successfully manage the AF patient in the short stay unit, thus optimizing patient outcomes, patient satisfaction, and operational efficiencies. Short Stay Management of Atrial Fibrillation is a valuable resource for cardiologists, emergency medicine physicians, electrophysiologists, and other healthcare professionals involved in AF management.
Contents
Part I. Impact of the Disease -- 1. Atrial Fibrillation: Epidemiology and Demographics -- 2. Pathophysiology of Atrial Fibrillation and Clinical Correlations -- 3. The Economic Impact of Atrial Fibrillation in the US -- Part II. Presentation and Management -- 4. Emergency Medical Services and Atrial Fibrillation -- 5. Symptoms of Atrial Fibrillation -- 6. Stroke and Other Complications of Atrial Fibrillation -- 7. Rate Control in Atrial Fibrillation -- 8. Diagnostic Testing in the Emergency Department of Atrial Fibrillation -- 9. Anticoagulation for Atrial Fibrillation in the Emergency Department or Observation Unit -- 10. Cardioversion and Acute Atrial Fibrillation Management -- 11. Procedural Sedation for Atrial Fibrillation Patients -- 12. Risk Stratification in Atrial Fibrillation and Observation Unit Entry -- 13. Cardiac Implantable Electronic Devices in the Short Stay Management of Atrial Fibrillation -- 14. Pitfalls in the Acute Management of Atrial Fibrillation -- Part III. Transition to the Outpatient Environment -- 15. Education of the Atrial Fibrillation Patient in the Observation Unit -- 16. Discharge Criteria -- 17. Discharge Planning -- 18. Outpatient Medications in Atrial Fibrillation -- Part IV. Systems Management -- 19. Atrial Fibrillation Accreditation -- 20. Quality Metrics in Atrial Fibrillation -- 21. Atrial Fibrillation Research in the Observation Unit and the Emergency Department -- 22. Atrial Fibrillation Protocols.
Format
e-Book
Location
Online
Less detail

11 records – page 1 of 1.